Search

Search Constraints

Start Over Filtering by: Keyword ibrutinib Remove constraint Keyword: ibrutinib

Search Results

  • A Phase 2 Trial of Ibrutinib and Nivolumab in Patients with Relapsed or Refractory Classical Hodgkin’s Lymphoma
  • Targeting the B cell receptor pathway in non-Hodgkin lymphoma